ACS Cancer Research Program

More in this category

• Cytoreduction with or without HIPEC: Where do we go from here?
• Robotic surgery for hepatic neoplasms: Where does it fit in the minimally invasive surgery landscape?
• Surveillance testing for colorectal cancer: New evidence supports a change in guidelines
• Colorectal cancer in adults younger than 50 years old
• The evolving clinical management of sentinel node-positive melanoma: The impact of MSLT-II on clinical practice
• Liquid biopsies in cancer clinical trials
• Geriatric assessment and frailty in older cancer patients
• Immunotherapy in solid tumors
• Duration of adjuvant therapy for stage III colon cancer: No longer one size fits all
• Adjuvant therapies for biliary tract cancers
• Improving surgical care and outcomes through the OPTI-Surg toolkit
• Surgical management of ADH, ALH, and LCIS
• Clinical trials for surgeons: Hurdles and opportunities
• Present and future cancer staging with the eighth edition of the AJCC Cancer Staging Manual
• Induction chemotherapy and minimally invasive transanal surgery to increase organ preservation in rectal cancer
• Preventing colorectal adenomas in cancer survivors: An update on the PACES/S0820 trial
• ACS CRP sponsors educational sessions at Clinical Congress 2017
• Current role of immunotherapy in urologic cancers
• Gastrectomy for cancer: What are the benefits of a minimally invasive approach?
• ACS CRP Dissemination and Implementation Committee issues call for participants in pilot project